All Stories

  1. Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies

    Article • September 2020, Springer Science + Business Media

    Dr Ioannis Psallidas

  2. Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight

    Article • Cells, August 2019, MDPI AG

    Dr Ioannis Psallidas

  3. Palliative care in mesothelioma: Are current services RESPECT-able enough?

    Article • Thorax, March 2019, BMJ

    Dr Ioannis Psallidas

  4. Response

    Article • CHEST Journal, March 2019, Elsevier

    Dr Ioannis Psallidas

  5. Respiratory training in Greece

    Article • Breathe, August 2017, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  6. Landmark studies for targeted treatments in lung cancer

    Article • Breathe, June 2016, European Respiratory Society (ERS)

    Dr Ioannis Psallidas, Dr Tiago Jacinto

  7. Advances in pleural disease

    Article • European Respiratory Review, May 2016, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  8. Malignant pleural effusion: from bench to bedside

    Article • European Respiratory Review, May 2016, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  9. Safe site selection for chest drain insertion by trainee physicians — Implications for medical training and clinical practice

    Article • European Journal of Internal Medicine, March 2016, Elsevier

    Dr Ioannis Psallidas

  10. Always Worth Another Look? Thoracic Ultrasonography before, during, and after Pleural Intervention

    Article • Annals of the American Thoracic Society, January 2016, American Thoracic Society

    Dr Ioannis Psallidas

  11. Medical thoracoscopy: Survey of current practice-How successful are medical thoracoscopists at predicting malignancy?

    Article • Respirology, December 2015, Wiley

    Dr Ioannis Psallidas

  12. Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion

    Article • JAMA, December 2015, American Medical Association (AMA)

    Dr Ioannis Psallidas

  13. Diagnostic value of radiological imaging pre‐ and post‐drainage of pleural effusions

    Article • Respirology, November 2015, Wiley

    Dr Ioannis Psallidas

  14. Draining pleural effusions before radiological imaging does not improve diagnostic capability

    Article • September 2015, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  15. Intrapleural tPA increases pleural fluid output in pleural infection, independent of chest X-ray opacification

    Article • September 2015, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  16. Patient-related outcome measurements in pleural diseases

    Article • September 2015, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  17. LSC Abstract – A requirement for mast cells in malignant pleural effusion

    Article • September 2015, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  18. Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growthin vivo

    Article • Respirology, August 2015, Wiley

    Dr Ioannis Psallidas

  19. Individualised management of malignant pleural effusion

    Article • The Lancet Respiratory Medicine, July 2015, Elsevier

    Dr Ioannis Psallidas

  20. Survival in Patients With Malignant Pleural Effusions Who Developed Pleural Infection

    Article • CHEST Journal, July 2015, Elsevier

    Dr Ioannis Psallidas

  21. Iatrogenic injury to the intercostal artery: aetiology, diagnosis and therapeutic intervention

    Article • Thorax, April 2015, BMJ

    Dr Ioannis Psallidas

  22. Mast cells mediate malignant pleural effusion formation

    Article • Journal of Clinical Investigation, April 2015, American Society for Clinical Investigation

    Dr Ioannis Psallidas

  23. Intercostal chest drain insertion by general physicians: attitudes, experience and implications for training, service and patient safety

    Article • Postgraduate Medical Journal, April 2015, BMJ

    Dr Ioannis Psallidas

  24. Interleukin-27 improves the ability of adenosine deaminase to rule out tuberculous pleural effusion regardless of pleural tuberculosis prevalence

    Article • Infectious Diseases, March 2015, Taylor & Francis

    Dr Ioannis Psallidas

  25. Ultrasound-guided pneumothorax induction prior to local anaesthetic thoracoscopy: Table 1

    Article • Thorax, February 2015, BMJ

    Dr Ioannis Psallidas

  26. A 63-year-old man with a recurrent right-sided pleural effusion: Figure 1

    Article • Thorax, January 2015, BMJ

    Dr Ioannis Psallidas

  27. Management of Parapneumonic Effusions and Empyema

    Article • Seminars in Respiratory and Critical Care Medicine, December 2014, Thieme Publishing Group

    Dr Ioannis Psallidas

  28. Tuberculous pleuritis secondary toMycobacterium bovisin a veterinarian

    Article • The Clinical Respiratory Journal, November 2014, Wiley

    Dr Ioannis Psallidas

  29. Physician-Based Ultrasound-Guided Biopsy for Diagnosing Pleural Disease

    Article • CHEST Journal, October 2014, Elsevier

    Dr Ioannis Psallidas

  30. Image of the month: A misleading chest X-ray - not all opacification is effusion

    Article • Clinical Medicine, October 2014, Royal College of Physicians

    Dr Ioannis Psallidas

  31. Staphylococcus aureusbio-products: New biological roles for a pleurodesis agent

    Article • Respirology, August 2014, Wiley

    Dr Ioannis Psallidas

  32. Reexpansion Pulmonary Edema Following Local Anesthetic Thoracoscopy

    Article • CHEST Journal, August 2014, Elsevier

    Dr Ioannis Psallidas

  33. Paracetamol and ibuprofen block hydrothorax absorption in mice

    Article • European Journal of Cardio-Thoracic Surgery, June 2014, Oxford University Press (OUP)

    Dr Ioannis Psallidas

  34. Interleukin-18 is up-regulated in infectious pleural effusions

    Article • Cytokine, August 2013, Elsevier

    Dr Nikoletta Rovina, Dr Ioannis Psallidas

  35. Interleukin‐17A is involved in bacteria‐related acute pleural inflammation

    Article • Respirology, March 2013, Wiley

    Dr Ioannis Psallidas

  36. Inhibition Of Osteopontin Modulates Tumor-Stimulated Immune Response And Suppresses Mesothelioma Progression

    Article • May 2012, American Thoracic Society

    Dr Ioannis Psallidas

  37. Abstract 2873: Opposing effects of NF-κB inhibition during chemical lung carcinogenesis

    Article • Cancer Research, April 2012, American Association for Cancer Research (AACR)

    Dr Ioannis Psallidas

  38. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion

    Article • Oncogene, February 2012, Nature

    Dr Ioannis Psallidas

  39. Opposing effects of bortezomib-induced nuclear factor- B inhibition on chemical lung carcinogenesis

    Article • Carcinogenesis, January 2012, Oxford University Press (OUP)

    Dr Ioannis Psallidas

  40. Neutralization of Tumor Necrosis Factor Bioactivity Ameliorates Urethane-Induced Pulmonary Oncogenesis in Mice

    Article • Neoplasia, December 2011, Elsevier

    Dr Ioannis Psallidas

  41. A sulindac analogue is effective against malignant pleural effusion in mice

    Article • Lung Cancer, August 2011, Elsevier

    Dr Ioannis Psallidas

  42. Static and dynamic mechanics of the murine lung after intratracheal bleomycin

    Article • BMC Pulmonary Medicine, January 2011, Springer Science + Business Media

    Dr Ioannis Psallidas

  43. Secreted Phosphoprotein-1 Enhances Urethane-induced Lung Carcinogenesis

    Article • May 2010, American Thoracic Society

    Dr Ioannis Psallidas

  44. Osteopontin Is Important For Malignant Pleural Effusion Formation

    Article • May 2010, American Thoracic Society

    Dr Ioannis Psallidas

  45. Dexamethasone acutely accelerates pleural fluid absorption in mice hydrothoraces

    Article • The Journal of Physiological Sciences, April 2010, Springer Science + Business Media

    Dr Ioannis Psallidas

  46. Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study

    Article • Molecular Cancer, January 2010, Springer Science + Business Media

    Dr Ioannis Psallidas

  47. Protective Effects of Mastic Oil FromPistacia LentiscusVariationChiaAgainst Experimental Growth of Lewis Lung Carcinoma

    Article • Nutrition and Cancer, September 2009, Taylor & Francis

    Dr Ioannis Psallidas

  48. Osteopontin is upregulated in malignant and inflammatory pleural effusions

    Article • Respirology, July 2009, Wiley

    Dr Ioannis Psallidas

  49. Etanercept-induced pleuropericardial lupus-like syndrome

    Article • European Respiratory Journal, April 2009, European Respiratory Society (ERS)

    Dr Ioannis Psallidas

  50. The Angiopoietin/Tie2 Axis Mediates Malignant Pleural Effusion Formation

    Article • Neoplasia, March 2009, Elsevier

    Dr Ioannis Psallidas

  51. A Central Role for Tumor-derived Monocyte Chemoattractant Protein-1 in Malignant Pleural Effusion

    Article • JNCI Journal of the National Cancer Institute, October 2008, Oxford University Press (OUP)

    Dr Ioannis Psallidas

  52. Zoledronic Acid Is Effective against Experimental Malignant Pleural Effusion

    Article • American Review of Respiratory Disease, July 2008, American Thoracic Society

    Dr Ioannis Psallidas

  53. Tumor Necrosis Factor-  Promotes Malignant Pleural Effusion

    Article • Cancer Research, October 2007, American Association for Cancer Research (AACR)

    Dr Ioannis Psallidas

  54. The efficacy of sonographic and biological pleurodesis indicators of malignant pleural effusion (SIMPLE)

    Article • Springer Science + Business Media

    Dr Ioannis Psallidas